左心室辅助装置患者多系统器官衰竭死亡路径分析
基于STS Intermacs注册库2006-2015年536例LVAD植入后3765例不良事件,采用层次聚类和Markov模型分析导致MSOF死亡的事件序列。识别出早死簇(418例,中位生存1个月)和晚死簇(118例,中位生存11个月),主要序列分别为肾衰竭→呼吸衰竭→死亡(62%)和出血→感染→呼吸衰竭→死亡(45%)。
要点
- LVAD后MSOF死亡可分为早死和晚死两个不同事件序列簇
- 早死簇以肾衰竭→呼吸衰竭→死亡为主,中位生存1个月
- 晚死簇以出血→感染→呼吸衰竭→死亡为主,中位生存11个月
核心结论
- LVAD患者MSOF死亡存在两种不同的事件序列簇,早死簇在肾和呼吸并发症后死亡,晚死簇在慢性出血和反复感染后死亡但生存期较长。
研究设计与样本
- 回顾性分析STS Intermacs注册库2006-2015年536例LVAD植入后3765例导致MSOF死亡的不良事件,采用层次聚类、Markov建模和Cox比例风险模型。
主要发现
- 早死簇418例(2304例AE),中位生存1个月(四分位距3-6个月);晚死簇118例(1461例AE),中位生存11个月(四分位距6-22个月)。
- 早死簇主要AE序列为肾衰竭→呼吸衰竭→死亡(62%)。
- 晚死簇主要AE序列为出血→感染→呼吸衰竭→死亡(45%)。
- MSOF的显著风险校正术前预测因素包括导管相关脓毒症(HR 3.0;95%CI 1.1-8.2)、ECMO(HR 2.2;95%CI 1.2-3.9)和透析或超滤(HR 2.1;95%CI 1.5-3.0)。
临床怎么用
- 对LVAD术后出现肾衰竭或呼吸衰竭的患者应警惕早死簇路径,加强器官支持。
- 对反复出血和感染的患者需关注晚死簇路径,尽管生存期较长仍需积极干预。
- 术前导管相关脓毒症、ECMO和透析/超滤患者MSOF风险较高,应优化术前管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study delineates the sequences of adverse events (AEs) preceding mortality attributed to multisystem organ failure (MSOF) in patients with a left ventricular assist device (LVAD). METHODS: We analyzed 3765 AEs after 536 LVAD implants recorded in The Society of Thoracic Surgeons Intermacs data registry between 2006 and 2015 that resulted in MSOF death. Hierarchical clustering identified and visualized quantitatively unique clusters of patients with similar AE profiles. Markov modeling was used to illustrate the AE sequences that led to MSOF death within the clusters. Cox proportional hazard models determined the risk-adjusted, preimplant predictors of MSOF. RESULTS: We identified 2 distinct MSOF clusters based on their proportion of AE types and survival time. The early-death cluster (418 patients, 2304 AEs) had a median survival of 1 month (interquartile range, 3-6 months), whereas the late-death cluster (118 patients, 1,461 AEs) had a median survival of 11 months (interquartile range, 6-22 months). The predominant AE sequences in the early-death and late-death clusters were renal failure, to respiratory failure, to death (62%) and bleeding, to infection, to respiratory failure, to death (45%), respectively. Significant risk-adjusted preimplant predictors of MSOF included line sepsis (hazard ratio [HR] 3.0; 95% confidence interval [CI], 1.1-8.2), extracorporeal membrane oxygenation (HR, 2.2; 95% CI, 1.2-3.9), and dialysis or ultrafiltration (HR, 2.1; 95% CI, 1.5-3.0). CONCLUSIONS: This analysis identified 2 AE clusters and the predominant sequences that result in MSOF-associated mortality. MSOF develops in 1 cluster of patients after chronic bleeding and repeated infections but has prolonged survival, while another group dies early after renal and respiratory complications.
引用
- Seese L, Movahedi F, Antaki J, et al. Delineating Pathways to Death by Multisystem Organ Failure in Patients With a Left Ventricular Assist Device. Ann Thorac Surg. 2020. PMID: 32739256. doi:10.1016/j.athoracsur.2020.05.164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。